The fact that the expression of MT1 and MT2 genes seems to have important action during the first stages of bone-forming cell differentiation is an interesting starting point that strengthens the hypothesis put forward about the possible causes of failure of implants, and the lack of osseointegration, in Down syndrome patients. This evidence concerns the gene MT1A and Down syndrome.